- Fresenius Kabi sold its Chilean subsidiary Laboratorio Sanderson S.A. and its IV manufacturing plant in Santiago to Medifarma
September 02 2024 08:00:40 UTC– Fresenius Kabi sells IV production site in Chile to Medifarma, a pharmaceutical company from Peru, as part of streamlining efforts for Fresenius Kabi. The divestment includes the IV Laboratorio Sanderson plant in Santiago de Chile.
Parenteral nutrition
The producer is known for blood volume replacement, anesthesia and parenteral nutrition and is the leading company in these product areas. Sanderson has a high-quality range of antibiotics, analgesics, anesthetics and infusion solutions and distributes products in Chile and other Latin American countries.
Existing Products
Medifarma will continue manufacturing existing products, while Fresenius Kabi remains committed to the Chilean and South American markets. This move aims to simplify and optimize Fresenius Kabi’s global production network, Fresenius said.
Fresenius had bought into the market by acquiring Laboratorio Sanderson S.A. in 2008.